Pharmaceutical industry
Biodel Inc. Announces Positive Preliminary Results from Phase 1 Clinical Trial for Glucagon Emergency Management Device
Biodel Inc. recently announced positive preliminary results from Study 6-101, a Phase 1 clinical trial comparing the company's lyophilized glucagon formulation BIOD-961 to Eli Lilly's Glucagon Emergency Rescue Kit and Novo Nordisk's GlucaGen HypoKit, both marketed for the treatment of severe hypoglycemia. The study